These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 23203967
1. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries. Siangjong L, Gauthier KM, Pfister SL, Smyth EM, Campbell WB. Am J Physiol Heart Circ Physiol; 2013 Feb 01; 304(3):H382-92. PubMed ID: 23203967 [Abstract] [Full Text] [Related]
2. Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries. Siangjong L, Goldman DH, Kriska T, Gauthier KM, Smyth EM, Puli N, Kumar G, Falck JR, Campbell WB. Acta Physiol (Oxf); 2017 Jan 01; 219(1):188-201. PubMed ID: 26666460 [Abstract] [Full Text] [Related]
3. Macrophage 12(S)-HETE Enhances Angiotensin II-Induced Contraction by a BLT2 (Leukotriene B4 Type-2 Receptor) and TP (Thromboxane Receptor)-Mediated Mechanism in Murine Arteries. Kriska T, Herrnreiter A, Pfister SL, Adebesin A, Falck JR, Campbell WB. Hypertension; 2022 Jan 01; 79(1):104-114. PubMed ID: 34784723 [Abstract] [Full Text] [Related]
4. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D, Zhou Y. Exp Physiol; 2012 Feb 01; 97(2):277-89. PubMed ID: 22080487 [Abstract] [Full Text] [Related]
5. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K. J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1352-61. PubMed ID: 8138950 [Abstract] [Full Text] [Related]
6. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J. Br J Pharmacol; 1996 Mar 01; 117(6):1171-80. PubMed ID: 8882612 [Abstract] [Full Text] [Related]
7. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation. Li P, Fukuhara M, Diz DI, Ferrario CM, Brosnihan KB. J Pharmacol Exp Ther; 2000 Jan 01; 292(1):238-46. PubMed ID: 10604953 [Abstract] [Full Text] [Related]
8. The angiotensin AT2-receptor agonist compound 21 is an antagonist for the thromboxane TP-receptor - Implications for preclinical studies and future clinical use. Fredgart MH, Leurgans TM, Stenelo M, Nybo M, Bloksgaard M, Lindblad L, De Mey JGR, Steckelings UM. Peptides; 2023 Jun 01; 164():170990. PubMed ID: 36894067 [Abstract] [Full Text] [Related]
13. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Randriamboavonjy V, Kiss L, Falck JR, Busse R, Fleming I. Cardiovasc Res; 2005 Feb 01; 65(2):487-94. PubMed ID: 15639488 [Abstract] [Full Text] [Related]
14. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies. Wilkes BM, Mento PF, Hollander AM. Placenta; 1994 Dec 01; 15(8):845-55. PubMed ID: 7886025 [Abstract] [Full Text] [Related]
15. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, Yao X, Yao T, Huang Y. Biochem Pharmacol; 2009 Aug 15; 78(4):374-81. PubMed ID: 19409373 [Abstract] [Full Text] [Related]
16. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets. Ohkubo S, Nakahata N, Ohizumi Y. Br J Pharmacol; 1996 Mar 15; 117(6):1095-104. PubMed ID: 8882602 [Abstract] [Full Text] [Related]
17. Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+ profiles and Ca2+ sensitisation of constriction of pressurised rat resistance arteries. Shaw L, O'Neill S, Jones CJ, Austin C, Taggart MJ. Br J Pharmacol; 2004 Feb 15; 141(4):678-88. PubMed ID: 14744813 [Abstract] [Full Text] [Related]